Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case
Joint Authors
Sorleto, Michele
Dürrwald, Stefanie
Wiemer, Marcus
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-07-21
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line.
Myocarditis is recognized as a very rare possible side effect of this drug treatment.
We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication.
American Psychological Association (APA)
Sorleto, Michele& Dürrwald, Stefanie& Wiemer, Marcus. 2015. Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case. Case Reports in Cardiology،Vol. 2015, no. 2015, pp.1-2.
https://search.emarefa.net/detail/BIM-1058151
Modern Language Association (MLA)
Sorleto, Michele…[et al.]. Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case. Case Reports in Cardiology No. 2015 (2015), pp.1-2.
https://search.emarefa.net/detail/BIM-1058151
American Medical Association (AMA)
Sorleto, Michele& Dürrwald, Stefanie& Wiemer, Marcus. Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case. Case Reports in Cardiology. 2015. Vol. 2015, no. 2015, pp.1-2.
https://search.emarefa.net/detail/BIM-1058151
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1058151
